Intractable diffuse pulmonary diseases: Manual for diagnosis and treatment

Authors: Homma, Sakae, Ebina, Masahito, Kuwano, Kazuyoshi, Goto, Hisatsugu, Sakai, Fumikazu, Sakamoto, Susumu, Johkoh, Takeshi, Sugino, Keishi, Tachibana, Teruo, Terasaki, Yasahiro, Nishioka, Yasuhiko, Hagiwara, Koichi, Hashimoto, Naozumi, Hasegawa, Yoshinori, Hebisawa, Akira

Source: In Respiratory Investigation January 2021 59(1):8-33

Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes

Authors: Afroj, Tania, Mitsuhashi, Atsushi, Ogino, Hirokazu, Saijo, Atsuro, Otsuka, Kenji, Yoneda, Hiroto, Tobiume, Makoto, Nguyen, Na Thi, Goto, Hisatsugu, Koyama, Kazuya

Source: Journal of immunology. 206(6):1204-1214

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626411999&indx=1&recIds=ETOCRN626411999

Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain

Authors: Kawano, Hiroshi, Koyama, Kazuya, Nishimura, Haruka, Toyoda, Yuko, Kagawa, Kozo, Sato, Seidai, Naito, Nobuhito, Goto, Hisatsugu, Inagaki, Yutaka, Nishioka, Yasuhiko

Source: Immunity, inflammation and disease. 9(1):120-127

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114265950.0x000001&indx=1&recIds=ETOCvdc_100114265950.0x000001

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells

Authors: Otsuka, Kenji, Mitsuhashi, Atsushi, Goto, Hisatsugu, Hanibuchi, Masaki, Koyama, Kazuya, Ogawa, Hirohisa, Ogino, Hirokazu, Saijo, Atsuro, Kozai, Hiroyuki, Yoneda, Hiroto, Tobiume, Makoto, Kishuku, Masatoshi, Ishizawa, Keisuke, Nishioka, Yasuhiko ^*

Source: In Lung Cancer August 2020 146:86-96

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Authors: Batagelj, Emilio, Casarini, Ignacio, Pastor, Anea Viviana, Sena, Susana Noemi, Zarba, Juan Jose, Burghuber, Otto, Hartl, Sylvia, Hochmair, Maximilian J, Lamprecht, Bernd, Studnicka, Michael, Alberto Schlittler, Luis, Augusto Martinelli de Oliveira, Fabricio, Calabrich, Aknar, Colagiovanni Girotto, Gustavo, Dos Reis, Peo, Fausto Nino Gorini, Carlos, Rafael Martins De Marchi, Peo, Serodio da Rocha Baldotto, Clarissa, Sette, Claudia, Zukin, Mauro, Conev, Nikolay V, Dudov, Assen, Ilieva, Rumyana, Koynov, Krassimir, Krasteva, Rositsa, Tonev, Ivan, Valev, Spartak, Venkova, Violetka, Bi, Minghong, Chen, Chengshui, Chen, Yuan, Chen, Zhendong, Fang, Jian, Feng, Jifeng, Han, Zhigang, Hu, Jie, Hu, Yi, Li, Wei, Liang, Zongan, Lin, Zhong, Ma, Rui, Ma, Shenglin, Nan, Kejun, Shu, Yongqian, Wang, Kai, Wang, Mengzhao, Wu, Gang, Yang, Nong, Yang, Zhixiong, Zhang, Helong, Zhang, Wei, Zhao, Jun, Zhao, Yanqiu, Zhou, Caicun, Zhou, Jianying, Zhou, Xiangdong, Havel, Libor, Kolek, Vitezslav, Koubkova, Leona, Roubec, Jaromir, Skrickova, Jana, Zemanova, Milada, Chouaid, Christos, Hilgers, Werner, Lena, Hervé, Moro-Sibilot, Denis, Robinet, Gilles, Souquet, Pierre-Jean, Alt, Jürgen, Bischoff, Helge, Grohe, Christian, Laack, Eckart, Lang, Susanne, Panse, Jens, Reinmuth, Niels, Schulz, Christian, Bogos, Krisztina, Csánky, Eszter, Fülöp, Anea, Horváth, Zsolt, Kósa, Judit, Laczó, Ibolya, Losonczy, György, Pajkos, Gábor, Pápai, Zsuzsanna, Pápai Székely, Zsolt, Sárosi, Veronika, Somfay, Attila, Somogyiné Ezer, Éva, Telekes, Anás, Bar, Jair, Gottfried, Maya, Heching, Norman Isaac, Zer Kuch, Alona, Bartolucci, Roberta, Bettini, Anna Cecilia, Delmonte, Angelo, Garassino, Marina Chiara, Minelli, Mauro, Roila, Fausto, Verderame, Francesco, Atagi, Shinji, Azuma, Koichi, Goto, Hisatsugu, Goto, Koichi, Hara, Yu, Hayashi, Hidetoshi, Hida, Toyoaki, Hotta, Katsuyuki, Kanazawa, Kenya, Kanda, Shintaro, Kim, Young Hak, Kuyama, Shoichi, Maeda, Tadashi, Morise, Masahiro, Nakahara, Yasuharu, Nishio, Makoto, Nogami, Naoyuki, Okamoto, Isamu, Saito, Haruhiro, Shinoda, Masahiro, Umemura, Shigeki, Yoshida, Tatsuya, Claessens, Niels, Cornelissen, Robin, Heniks, Lizza, Hiltermann, Jeroen, Smit, Egbert, Staal van den Brekel, Agnes, Kazarnowicz, Andrzej, Kowalski, Dariusz, Mańdziuk, Slawomir, Mróz, Robert, Wojtukiewicz, Marek, Ciuleanu, Tudor, Ganea, Doina, Ungureanu, Anei, Dvorkin, Mikhail, Luft, Alexander, Moiseenko, Vladimir, Poltoratskiy, Artem, Sakaeva, Dina, Smolin, Alexey, Statsenko, Galina, Vasilyev, Alexander, Vladimirova, Lyubov, Anasina, Igor, Chovanec, Jozef, Demo, Pavol, Godal, Robert, Kasan, Peter, Stresko, Marian, Urda, Michal, Cho, Eun Kyung, Ji, Jun Ho, Kim, Joo-Hang, Kim, Sang-We, Lee, Gyeong-Won, Lee, Jong-Seok, Lee, Ki Hyeong, Lee, Kyung Hee, Lee, Yun Gyoo, Amelia Insa Molla, Maria, Domine Gomez, Manuel, Ignacio Delgado Mingorance, Juan, Isla Casado, Dolores, Lopez Brea, Marta, Majem Tarruella, Margarita, Morán Bueno, Teresa, Navarro Mendivil, Alejano, Paz-Ares Rodríguez, Luis, Ponce Aix, Santiago, Rosario Garcia Campelo, Maria, Chang, Gee-Chen, Chen, Yen-Hsun, Chiu, Chao-Hua, Hsia, Te-Chun, Lee, Kang-Yun, Li, Chien-Te, Wang, Chin-Chou, Wei, Yu-Feng, Wu, Shang-Yin, Alacacıoğlu, Ahmet, Çiçin, Irfan, Demirkazik, Ahmet, Erman, Mustafa, Göksel, Tuncay, Özgüroğlu, Mustafa, Adamchuk, Hryhoriy, Bondarenko, Igor, Kolesnik, Oleksii, Kryzhanivska, Anna, Ostapenko, Yuriv, Shevnia, Serhii, Shparyk, Yaroslav, Trukhin, Dmytro, Ursol, Grygorii, Voitko, Nataliia, Voitko, Oleksandr, Vynnychenko, Ihor, Babu, Sunil, Chen, Yuanbin, Chiang, Anne, Chua, Winston, Dakhil, Shaker, Dowlati, Afshin, Goldman, Jonathan W, Haque, Basir, Jamil, Rodney, Knoble, Jeanna, Lakhanpal, Shailena, Mi, Kailhong, Nikolinakos, Petros, Powell, Steven, Ross, Helen, Schaefer, Eric, Schneider, Jeffrey, Spahr, Joseph, Spigel, David, Stilwill, Joseph, Sumey, Christopher, Williamson, Michael, Paz-Ares, Luis ^*, Ponce, Santiago, Armstrong, Jon, Byrne, Natalie, Shire, Norah, Jiang, Haiyi

Source: In The Lancet 23-29 November 2019 394(10212):1929-1939

Clinical features of interstitial pneumonia associated with systemic lupus erythematosus

Authors: Toyoda, Yuko, Koyama, Kazuya, Kawano, Hiroshi, Nishimura, Haruka, Kagawa, Kozo, Morizumi, Shun, Naito, Nobuhito, Sato, Seidai, Yamashita, Yuya, Takahashi, Naoki, Goto, Hisatsugu, Azuma, Masahiko, Nishioka, Yasuhiko

Source: In Respiratory Investigation September 2019 57(5):435-443

The clinical features of older patients with lung cancer in comparison with their younger counterparts

Authors: Ogino, Hirokazu, Hanibuchi, Masaki, Sakaguchi, Satoshi, Toyoda, Yuko, Tezuka, Toshifumi, Kawano, Hiroshi, Kakiuchi, Soji, Otsuka, Kenji, Saijo, Atsuro, Azuma, Masahiko, Nokihara, Hiroshi, Goto, Hisatsugu, Nishioka, Yasuhiko

Source: In Respiratory Investigation January 2019 57(1):40-48

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease

Authors: Hanibuchi, Masaki, Kakiuchi, Soji, Atagi, Shinji, Ogushi, Fumitaka, Shimizu, Eiji, Haku, Takashi, Toyoda, Yuko, Azuma, Masahiko, Kondo, Mayo, Kawano, Hiroshi, Otsuka, Kenji, Sakaguchi, Satoshi, Nokihara, Hiroshi, Goto, Hisatsugu, Nishioka, Yasuhiko

Source: In Lung Cancer November 2018 125:93-99

Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells

Authors: Saijo, Atsuro, Goto, Hisatsugu, Nakano, Mayuri, Mitsuhashi, Atsushi, Aono, Yoshinori, Hanibuchi, Masaki, Ogawa, Hirohisa, Uehara, Hisanori, Kondo, Kazuya, Nishioka, Yasuhiko

Source: In Cancer Letters 1 May 2018 421:17-27

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer

Authors: Goto, Hisatsugu, Okano, Yoshio, Machida, Hisanori, Hatakeyama, Nobuo, Ogushi, Fumitaka, Haku, Takashi, Kanematsu, Takanori, Urata, Tomoyuki, Kakiuchi, Soji, Hanibuchi, Masaki, Sone, Saburo, Nishioka, Yasuhiko

Source: In Respiratory Investigation January 2018 56(1):80-86

The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice

Authors: Okazaki, Hiroyasu, Sato, Seidai, Koyama, Kazuya, Morizumi, Shun, Abe, Shuichi, Azuma, Momoyo, Chen, Yajuan, Goto, Hisatsugu, Aono, Yoshinori, Ogawa, Hirohisa, Kagawa, Kozo, Nishimura, Haruka, Kawano, Hiroshi, Toyoda, Yuko, Uehara, Hisanori, Kouji, Hiroyuki, Nishioka, Yasuhiko

Source: Experimental lung research. 45(7):188-199

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100105907919.0x000001&indx=1&recIds=ETOCvdc_100105907919.0x000001

A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis

Authors: Takezaki, Akio, Tsukumo, Shin-ichi, Setoguchi, Yasuhiro, Ledford, Julie G., Goto, Hisatsugu, Hosomichi, Kazuyoshi, Uehara, Hisanori, Nishioka, Yasuhiko, Yasutomo, Koji

Source: Journal of experimental medicine. 216(12):2724-2735

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN622359088&indx=1&recIds=ETOCRN622359088

Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1

Authors: Kakiuchi, Soji, Hanibuchi, Masaki, Tezuka, Toshifumi, Saijo, Atsuro, Otsuka, Kenji, Sakaguchi, Satoshi, Toyoda, Yuko, Goto, Hisatsugu, Kawano, Hiroshi, Azuma, Masahiko, Ogushi, Fumitaka, Nishioka, Yasuhiko

Source: In Respiratory Investigation March 2017 55(2):145-152

An analysis of the clinical features of lung cancer in patients with connective tissue diseases

Authors: Saijo, Atsuro, Hanibuchi, Masaki, Goto, Hisatsugu, Toyoda, Yuko, Tezuka, Toshifumi, Nishioka, Yasuhiko

Source: In Respiratory Investigation March 2017 55(2):153-160

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity

Authors: Sato, Seidai, Shinohara, Shintaro, Hayashi, Shinya, Morizumi, Shun, Abe, Shuichi, Okazaki, Hiroyasu, Chen, Yanjuan, Goto, Hisatsugu, Aono, Yoshinori, Ogawa, Hirohisa, Koyama, Kazuya, Nishimura, Haruka, Kawano, Hiroshi, Toyoda, Yuko, Uehara, Hisanori, Nishioka, Yasuhiko

Source: Respiratory research. 18(1):1-11

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100141931357.0x000001&indx=1&recIds=ETOCvdc_100141931357.0x000001

Thymidine Catabolism as a Metabolic Strategy for Cancer Survival

Authors: Tabata, Sho, Yamamoto, Masatatsu, Goto, Hisatsugu, Hirayama, Akiyoshi, Ohishi, Maki, Kuramoto, Takuya, Mitsuhashi, Atsushi, Ikeda, Ryuji, Haraguchi, Misako, Kawahara, Kohichi, Shinsato, Yoshinari, Minami, Kentaro, Saijo, Atsuro, Hanibuchi, Masaki, Nishioka, Yasuhiko, Sone, Saburo, Esumi, Hiroyasu, Tomita, Masaru, Soga, Tomoyoshi, Furukawa, Tatsuhiko, Akiyama, Shin-ichi

Source: Cell reports. 19(7):1313-1321

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129131367.0x000001&indx=1&recIds=ETOCvdc_100129131367.0x000001

The Mechanism of Resistance to Anti—angiogenic Therapy Mediated by Fibrocytes in Lung Cancer

Authors: Goto, Hisatsugu

Source: Saishin igaku. 72(4):608-624

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN611024135&indx=1&recIds=ETOCRN611024135

A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer.

Authors: Yabuki, Yohei, Hanibuchi, Masaki, Takeuchi, Eiji, Haku, Takashi, Kanematsu, Takanori, Nishimura, Naoki, Toyoda, Yuko, Mitsuhashi, Atsushi, Otsuka, Kenji, Sato, Seidai, Goto, Hisatsugu, Yoneda, Hiroto, Ogino, Hirokazu, Nokihara, Hiroshi, Tsutomu, Shinohara, Nishioka, Yasuhiko

Source: Thoracic Cancer; Nov2023, Vol. 14 Issue 32, p3232-3239, 8p

Subject Terms: LUNG cancer, DRUG efficacy, RESEARCH, ADENOCARCINOMA, DISEASE progression, CLINICAL trials, CANCER chemotherapy, ANTINEOPLASTIC agents, DISEASE relapse, PRE-tests & post-tests, COMPARATIVE studies, TREATMENT effectiveness, DESCRIPTIVE statistics, BEVACIZUMAB, PEMETREXED, OLD age

Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated Macrophages

Authors: Mitsuhashi, Atsushi, Goto, Hisatsugu, Kuramoto, Takuya, Tabata, Sho, Yukishige, Sawaka, Abe, Shinji, Hanibuchi, Masaki, Kakiuchi, Soji, Saijo, Atsuro, Aono, Yoshinori, Uehara, Hisanori, Yano, Seiji, Ledford, Julie G., Sone, Saburo, Nishioka, Yasuhiko

Source: In The American Journal of Pathology May 2013 182(5):1843-1853

A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition

Authors: Kondo, Mayo, Ogino, Hirokazu, Ogawa, Hirohisa, Afroj, Tania, Toyoda, Yuko, Sakaguchi, Satoshi, Tsuboi, Miki, Bando, Yoshimi, Goto, Hisatsugu, Tsuneyama, Koichi, Nishioka, Yasuhiko

Source: Respiratory medicine case reports. 25:119-121

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100087284338.0x000001&indx=1&recIds=ETOCvdc_100087284338.0x000001